Insider Transactions in Q1 2021 at Edgewise Therapeutics, Inc. (EWTX)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 30
2021
|
Peter A. Thompson |
BUY
Open market or private purchase
|
Indirect |
359,375
+7.54%
|
$5,750,000
$16.0 P/Share
|
|
Mar 30
2021
|
Peter A. Thompson |
BUY
Conversion of derivative security
|
Indirect |
13,002,760
+49.69%
|
-
|
|
Mar 30
2021
|
Jonathan D Root |
BUY
Open market or private purchase
|
Direct |
15,625
+50.0%
|
$250,000
$16.0 P/Share
|
|
Mar 30
2021
|
Jonathan D Root |
BUY
Conversion of derivative security
|
Indirect |
3,473,543
+50.0%
|
-
|
|
Mar 30
2021
|
Novo Holdings > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
625,000
+10.06%
|
$10,000,000
$16.0 P/Share
|
|
Mar 30
2021
|
Novo Holdings > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
4,962,207
+50.0%
|
-
|
|
Mar 30
2021
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
359,375
+7.54%
|
$5,750,000
$16.0 P/Share
|
|
Mar 30
2021
|
Orbimed Advisors LLC Director |
BUY
Conversion of derivative security
|
Indirect |
13,002,760
+49.69%
|
-
|
|
Mar 30
2021
|
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
681,812
+50.0%
|
-
|
|
Mar 30
2021
|
James E Flynn > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
625,000
+13.71%
|
$10,000,000
$16.0 P/Share
|
|
Mar 30
2021
|
James E Flynn > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,308,137
+30.92%
|
-
|